UPDATED Apr 24, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
TTE | €67.91 | 0.4% | 16.3% | €163.0b | €71.86 | PE8.2x | E-4.2% | 4.6% | ||
DPAM | €540.00 | 5.9% | 11.6% | €52.8m | n/a | PE10.9x | n/a | 7.0% | ||
ES | €167.00 | 10.0% | 276.0% | €2.1b | n/a | PE3.2x | n/a | 1.8% | ||
TE | €23.04 | 0.4% | 15.1% | €4.1b | €26.25 | PE13.8x | E13.9% | 2.5% | ||
VK | €16.76 | -5.6% | 62.0% | €3.9b | €20.83 | PE7.8x | E10.1% | 0% | ||
MAU | €6.22 | 0.3% | 80.6% | €1.2b | €5.73 | PE6.3x | E12.9% | 3.7% | ||
LHYFE | €4.28 | 0.9% | -38.8% | €204.9m | €5.53 | PS155.6x | E11.1% | n/a | ||
ALEO2 | €4.43 | -5.7% | -16.4% | €11.2m | n/a | PE2.5x | n/a | n/a | ||
GTT | €130.00 | -5.9% | 35.9% | €4.8b | €164.60 | PE23.9x | E12.7% | 3.9% | ||
FDE | €34.40 | 7.5% | 1.2% | €179.9m | €64.07 | PE22.9x | E32.3% | n/a | ||
EC | €169.50 | 0.9% | -6.5% | €762.8m | n/a | PE2.3x | n/a | 42.9% | ||
MLSEQ | €0.011 | 4.5% | -11.5% | €11.0m | n/a | PB1.1x | n/a | n/a |